has acted as consultant, advisory board member and speaker for Boehringer Ingelheim, Eli Lilly, Novo Nordisk and Sanofi, an advisory board member Lexicon, Pfizer, ShouTi Pharma Inc, AstraZeneca and Medtronic and as a speaker for AstraZeneca, Napp Pharmaceuticals, Novartis and Amgen
Your clinician should tailor this to your situation and, importantly, to the underlying cause of deficiency (dietary vs non-dietary)
As our results showed, there is no difference between them in terms of efficacy, but in terms of patients tolerance, advantages, and disadvantages of each route, the sublingual route is preferred over IM and oral routes
I wound up needing 1 1/2 inch needles, the only downside is they dont give you sizing options when buying their products
Dosing is individualized